Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

Resurrect Bio

London AgriTech Startup Resurrect Bio Secures €8.8 Million in Series A Funding Led by Corteva

May 14, 2026 by James O'Brien

Resurrect Bio, a London-based agricultural BioTech startup, closed an oversubscribed Series A funding round at €8.8 million ($10.3 million), led by Corteva through its Corteva Catalyst platform. The company had made an initial close of over €6.8 million in February 2026.

Categories Funding Tags €5M–€20M, Agritech, Resurrect Bio, Series A Leave a comment
Browse by Country

Latest

Manchester AI Platform Revnu Raises €2.6 Million to Expand Sales Automation Across Europe and USOct 1, 2026
Copenhagen AI Transcription Startup Good Tape Secures Fresh Funding to Launch Insight-Linking PlatformOct 1, 2026
London AI Recruiting Platform Metaview Raises €53.1 Million in Series C RoundOct 1, 2026
Luxembourg Cybersecurity Startup Osavul Secures €8.5M Series A to Expand Enterprise and Defence OperationsOct 1, 2026
Cluj-Napoca Transport Software Startup AtruX Launches Free Subscription Campaign for Small Fleet OperatorsOct 1, 2026

EU Markets

European Financial Markets Weekly: Billion-Dollar Raises, Banking Stress Tests, and What It All Means for Your StartupSep 25, 2026
Europe's Financial Markets Are Shifting — Here's What Startup Founders Need to Know This WeekSep 18, 2026
ECB Rate Hike, Banking M&A, and a Crypto Security Storm: What Europe's Financial Markets Mean for Startups This WeekSep 11, 2026
European Markets Signal Both Opportunity and Caution for Startups This WeekSep 4, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.